Exagen Inc (XGN) — Capital Reinvestment Ratio

Latest as of June 2026: 0.14x

Exagen Inc (XGN) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow ($3.99 Million) in capital expenditures ($543.00K). Check Exagen Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.14x

Capex / Operating Cash Flow

Operating Cash Flow

$3.99 Million

USD

Capital Expenditures

$543.00K

USD

Data as of

Jun 2026

Most recent filing

Annual Capital Reinvestment Ratio for Exagen Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Exagen Inc from None to None. See Exagen Inc (XGN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow